New Zealand Doctor | New Zealand Doctor
Cameron Schauer and Jason Robertson describe the symptoms, aetiology, subtypes and consequences of reflux. They also discuss the investigations used for diagnosis, investigating those with alarm features and evaluating success of treatment. Finally, they examine multimodal treatment, including lifestyle, pharmacological and surgical interventions.
Heart Foundation welcomes news of funded treatment for heart …
2 days ago · The Heart Foundation's call for wider access to a heart medication has been successful, with Pharmac announcing today that it will fund a drug used in the treatment of chronic heart failure, a move that will benefit more than 18,000 New Zealanders over the next 12 months. The drug (empagliflozin) will be available to people who have chronic ...
+All News | New Zealand Doctor
2 days ago · New Zealand Health Plan won’t be signed off until 2025 due to delays. The New Zealand Health Plan Te Pae Waenga is now not expected to be signed off by the health minister until next year, according to Te Whatu Ora director of planning and outcomes Lisa Williams. Read more. By Stephen Forbes. Monday 11 November 2024, 04:24 PM. 3 minutes to Read.
Covid-19 vaccines work, but we need to do more to get the most …
Aug 1, 2024 · Covid-19 vaccines work, but we need to do more to get the most out of them. While keeping up with your Covid-19 boosters is still the most effective way to protect yourself in the ongoing pandemic, infectious disease experts say we could get even better public health value from the vaccines. In the latest Briefing from the Public Health ...
Osteoporosis - New Zealand Doctor
Mar 27, 2024 · The ANZFFR Annual Report 2024 shows 95 per cent of anti-osteoporosis treatment used is either oral or intravenous bisphosphonate. Oral agents available in New Zealand are alendronate (Fosamax and Fosamax Plus) and risedronate, and the intravenous agent for use in osteoporosis is zoledronate.
Older Kiwis urged to get COVID-19 boosters | New Zealand Doctor
Dec 13, 2023 · As Kiwis prepare for Christmas, public health officials are recommending that people who are more likely to experience severe COVID-19, such as Māori and Pacific people aged 50 and over, as well as everyone aged 65 and older, get a booster vaccine before the holidays. Dr Nicholas Jones Director of Public Health says New Zealand has been ...
Thousands of Kiwis Set to Access Newly Funded ... - New Zealand …
Mar 1, 2023 · [1] Strezova A et al. Long-term protection against herpes zoster (HZ) by the adjuvanted recombinant zoster vaccine (RZV): interim efficacy, immune and safety results at approximately 10 years after initial vaccination. Open Forum Infectious Diseases. 2022 [2] Immunisation Advisory Centre. Shingrix. Accessible here. …
New diabetes data confirms ‘worst case’ predictions
3 days ago · The Economic and Social Cost of Type 2 Diabetes report released in 2021 predicted that by 2040 there would be up to 430,000 people living with type 2 diabetes in Aotearoa. The new data shows the figures are tracking well above this prediction. “We can’t sugar coat the size of the problem,” says Heather Verry, chief executive of Diabetes ...
New booster plan in time for winter | New Zealand Doctor
Feb 23, 2023 · New booster plan in time for winter. All New Zealanders aged 30 and over will be able to access the new COVID bivalent booster from April as part of the Government’s plan to keep Kiwis safe and take pressure off our health system, says Minister of Health Dr Ayesha Verrall. The new bivalent vaccine will replace the existing Pfizer booster and ...
Reflux | New Zealand Doctor
Nov 5, 2024 · Cameron Schauer and Jason Robertson describe the symptoms, aetiology, subtypes and consequences of reflux. They also discuss the investigations used for diagnosis, investigating those with alarm features and evaluating success of treatment. Finally, they examine multimodal treatment, including lifestyle, pharmacological and surgical interventions.